Drug Shortage Report for VINCRISTINE SULFATE INJECTION
Report ID | 144451 |
Drug Identification Number | 02143305 |
Brand name | VINCRISTINE SULFATE INJECTION |
Common or Proper name | VINCRISTINE SULFATE |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | VINCRISTINE SULFATE |
Strength(s) | 1MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 2ML |
ATC code | L01CA |
ATC description | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-10-10 |
Actual start date | |
Estimated end date | 2022-12-30 |
Actual end date | 2021-08-01 |
Shortage status | Avoided shortage |
Updated date | 2021-08-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2021-08-23 | French | Compare |
v3 | 2021-08-23 | English | Compare |
v2 | 2021-08-23 | French | Compare |
v1 | 2021-08-23 | English | Compare |
Showing 1 to 4 of 4